These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20516456)

  • 1. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
    J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
    Pezzolo A; Capra V; Raso A; Morandi F; Parodi F; Gambini C; Nozza P; Giangaspero F; Cama A; Pistoia V; Garrè ML
    Cancer Lett; 2008 Mar; 261(2):235-43. PubMed ID: 18179864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
    Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
    Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M
    Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
    Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
    Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
    J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
    Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
    Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.
    Dyer S; Prebble E; Davison V; Davies P; Ramani P; Ellison D; Grundy R
    Am J Pathol; 2002 Dec; 161(6):2133-41. PubMed ID: 12466129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
    Fouladi M; Helton K; Dalton J; Gilger E; Gajjar A; Merchant T; Kun L; Newsham I; Burger P; Fuller C
    Cancer; 2003 Nov; 98(10):2232-44. PubMed ID: 14601094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.